Calling the Tune on ESC Research: Therapies or Tools?
As the California stem cell agency wrestles with how to give away $3 billion – otherwise known as strategic planning – along comes a related article in the nation's most prestigious newspaper, the New York Times.
In Monday's edition, reporter Nicholas Wade discussed the split between those who want to see development of stem cell therapies versus those …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.